Day: January 6, 2022
SINGAPORE, Jan. 06, 2022 (GLOBE NEWSWIRE) — Cash Mart Singapore, a leading name in the lending industry, announced today that they acquired controlgreed.com, one of the web’s leading financial resources for struggling individuals and families.
Controlled Greed aims to inspire its readers to have stable finances and work towards their financial resilience and freedom.
This acquisition is an important step forward for Cash Mart, as it aspires to add even more value in the financial space especially in Southeast Asia.
Cash Mart Singapore’s goal is to devote a space for financial literacy such as budgeting, saving, responsible borrowing, facts about licensed money lenders in Singapore and investing in undervalued stocks.
In addition, some content will focus on typical and global investments such as net working capital, low price-to-earnings...
New independent Board member of AB Klaipėdos nafta elected
Written by Customer Service on . Posted in Public Companies.
The meeting of the Supervisory Council of AB Klaipėdos nafta (hereinafter – the Company) held on the 5th of January 2022 adopted a decision to elect Edvinas Katilius as an independent Board member of the Company to fill the existing vacancy to serve from 2nd of February 2022 until the term of office of the acting Board of the Company (24 April 2022).
An independent Board member has been elected on the basis that an independent Board member Bjarke Pålsson decided to resign from the position as the Board member of the Company from 1st of February 2022; article 15.1. of Articles of Association of the Company defines that the Board consists of 5 (five) members.
Head of Communication Orinta Barkauskaitė
o.barkauskaite@kn.lt, +370 611 27985
Dassault Aviation: Deliveries, order intakes and backlog in number of new aircraft as of December 31st 2021
Written by Customer Service on . Posted in Public Companies.
Dassault Aviation Group
Deliveries, order intakes and backlog in number of new aircraft as of December 31st 2021(unaudited figures)
AIRCRAFT DELIVERED IN 2021
30 Falcon were delivered, while 25 deliveries had been guided, versus 34 in 2020.
25 Export Rafale were delivered, in line with our guidance, versus 13 in 2020.
AIRCRAFT ORDERED IN 2021
51 Falcon were ordered, compared to 15 in 2020.
49 Rafale(*)were ordered (37 Export and 12 France). (*)This figure does not include the Rafale UAE contract which T0 is expected in 2022.
AIRCRAFT IN BACKLOG
As of December 31st 2021, the backlog includes:55 Falcon compared to 34 Falcon as of December 31st 2020,
86 Rafale compared to 62 Rafale as of December 31st 2020.UPCOMING FINANCIAL RELEASE
Dassault Aviation Group will release on March 4th 2022 its full year results.
The above figures relate...
New independent Board members of AB Klaipėdos nafta has been elected for a new term of office of four years
Written by Customer Service on . Posted in Public Companies.
The meeting of the Supervisory Council of AB Klaipėdos nafta (hereinafter – the Company) held on the 5th of January 2022 adopted a decision to elect the independent Board members for a new four-year term of office:Guy Mason
Edvinas Katilius
Alfonso Morriello
Jūratė LingienėThe new Board of the Company will take office from 25th April 2022, after the end of the term of office of the current Board of the Company.
The decision regarding fifth Board member of the Company will be adopted in a near future.
Head of Communication Orinta Barkauskaitėo.barkauskaite@kn.lt, +37061127985
Notification about results of final buy-back of shares
Written by Customer Service on . Posted in Public Companies.
Notification about results of final buy-back of shares
Target company
Joint Stock Company ” Olainfarm “, registration number 40003007246, legal address: Rupnicu str. 5, Olaine, LV-2114, Latvia, phone: (+371) 67013705, e-mail: olainfarm@olainfarm.com, website: www.olainfarm.com, hereinafter – Target Company.
Offeror
AS “AB CITY”, registration number 40203174414, date and place of registration 11.10.2018., Rīga, legal address: Ganību dambis 24D, Riga, LV-1005, e-mail: abcity@abcity.lv, website: www.abcity.lv, hereinafter – Offeror.
Number of shares offered for sale
A total of 549 837 shares of the Target Company have been offered for sale and alienated in accordance with the provisions of Article 83 of the Financial Instruments Market Law.
On January 4th, 2022, the Offeror purchased all 549 837 shares of the Target...
Key Dates for AIM Delisting
Written by Customer Service on . Posted in Public Companies.
Amryt Pharma plc – Key Dates for AIM Delisting
DUBLIN, Ireland, and Boston MA, January 6, 2022, Amryt Pharma plc (Nasdaq: AMYT, AIM: AMYT) (“Amryt” or the “Company”), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today reminds shareholders of the key dates concerning the cancellation of the admission of its ordinary shares of nominal value £0.06 each (the “Ordinary Shares”) to trading on AIM (the “AIM Delisting”), as originally announced on November 22, 2021.
As previously announced, the last day of trading in the Company’s Ordinary Shares on AIM will be January 10, 2022 and the proposed AIM Delisting will be effective from 7.00 a.m. (London time) on January 11, 2022. Amryt will retain the listing of its American Depositary Shares,...
Serabi interviewed by BRR Media to discuss high grade exploration drilling results at Palito, as well as Coringa progress
Written by Customer Service on . Posted in Public Companies.
For immediate release
6 January 2022
Serabi Gold plc(“Serabi” or the “Company”)
Serabi interviewed by BRR Media to discuss high grade exploration drilling results at Palito, as well as Coringa progress
Serabi Gold plc (AIM:SRB, TSX:SBI), the Brazilian-focused gold mining and development company, advise that Mike Hodgson, CEO of Serabi, has conducted an interview with BRR Media. The interview discusses the recently announced surface and underground exploration drill results into the Chico da Santa (“CDS”) sector and the first results into the newly discovered Pele sector at the Palito Gold Mine. Progress at the Company’s Coringa Gold Project is also discussed.
The interview can be accessed using the following link – https://www.brrmedia.co.uk/broadcasts-embed/61d578fe4f0a66712380e487/?popup=true
Interview HighlightsHighly encouraging...
More than 5 million vehicles now rely on TomTom’s maps for automated driving
Written by Customer Service on . Posted in Public Companies.
More than 5 million vehicles now rely on TomTom’s maps for automated drivingMore than 5 million vehicles now rely on TomTom’s maps for automated drivingTomTom ADAS Map supports over five million Level 1 and 2 automated vehicles
The growth of the TomTom ADAS Map outpaces industry as one of the most used automated driving technologies
TomTom HD Map sourced by three of the five leading global carmaker groups for their most advanced automated vehiclesAMSTERDAM, Jan. 06, 2022 (GLOBE NEWSWIRE) — TomTom (TOM2), the geolocation technology specialist, today announced new milestones for its advanced maps used in automated driving (AD) technologies.
Over five million SAE Level one and Level two automated vehicles (AV) sold by carmakers across North America and Europe rely on TomTom’s advanced driver assistance systems...
Home Infusion Therapy Market Size [2022-2028] | is Projected to Reach USD 54.82 Billion by 2028 and Exhibit a CAGR of 6.8%
Written by Customer Service on . Posted in Mergers And Acquisitions.
Key Players Covered in the Home Infusion Therapy Market Research Report are Optum, Inc., Infusystem, Option Care Health Inc., Moog Inc., CareCentrix, Inc., B. Braun Melsungen AG, Lincare Holdings Inc., Baxter, Promptcare, BriovaRx Infusion Services and other key market players.
Pune, India, Jan. 06, 2022 (GLOBE NEWSWIRE) — The global home infusion therapy market size is projected to reach USD 54.82 billion by 2028 and exhibit a CAGR of 6.8% during the forecast period. The growing demand for personalized intravenous drug infusion therapy is expected to be the key growth driver for the market. Fortune Business InsightsTM has presented this information in its report titled “Home Infusion Therapy Market, 2021-2028”. The market size stood at USD 41.36 billion in 2020 and is anticipated to reach USD 34.54 billion in 2021.The market’s...
Basilea reports on portfolio progress made in 2021
Written by Customer Service on . Posted in Public Companies.
Achieved important Cresemba® (isavuconazole) and Zevtera® (ceftobiprole) milestones
Added new clinical candidate BAL0891 to oncology pipeline and advanced clinical programs with derazantinib and lisavanbulinBasel, January 06, 2022
Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious diseases and cancer, provided today an update on the progress made with both its commercial brands and in its key research and development programs in 2021. The company achieved significant milestones and will continue to focus on delivering on its strategy for continued value creation in 2022.
David Veitch, Chief Executive Officer, commented: “Important milestones for our anti-infective brands included the marketing approval of Cresemba in China for the treatment...